ADCT News & Analysis

2 articles

Market Mood

0 Bullish2 Neutral0 Bearish
ADC Therapeutics SA (ADCT) Files Form 13G on April 24
MarketsNeutral4/25/2026

ADC Therapeutics SA (ADCT) Files Form 13G on April 24

ADC Therapeutics SA (ADCT) filed Form 13G on April 24. This document is typically filed by investors owning more than 5% of a company’s securities, indicating a significant stake. The filing reflects changes in beneficial ownership and is critical for transparency in market transactions. Monitoring such filings helps investors understand the shareholder dynamics that can influence stock performance.

Read More
ADC Therapeutics SA (ADCT) Files Form 13G on April 6
MarketsNeutral4/7/2026

ADC Therapeutics SA (ADCT) Files Form 13G on April 6

ADC Therapeutics SA (ADCT) submitted Form 13G on April 6, which is typically used to report beneficial ownership of securities by institutional investors. The filing reveals ownership stakes that may indicate significant investor interest or changes in equity positions. Such filings can influence market perception and trading volumes. Monitoring these filings is crucial for understanding investor sentiment towards ADCT.

Read More